INCLUSIVE
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu
4376
Cube
7112
日本市場個股詳情
3537 昭榮藥品
- 1569
- -16-1.01%
延時20分鐘行情已收盤 01/09 15:30 (東京)
56.16億總市值10.84市盈率(靜)
1586最高價1561最低價4200股成交量1586今開1585昨收661.21萬成交額158652周最高0.41%換手率357.91萬總股本120252周最低155.09每股收益TTM16.11億流通值1586歷史最高10.84市盈率(靜)102.70萬流通股551歷史最低144.75每股收益(静)1.58%振幅38.00股息TTM0.59市淨率100股每手2.42%股息率TTM
昭榮藥品關鍵統計數據
季報+年報
顯示同比
| (FY)2024/03/31 | (Q4)2024/03/31 | (Q3)2023/12/31 | (Q2)2023/09/30 | (Q1)2023/06/30 | (FY)2023/03/31 | (Q4)2023/03/31 | (Q3)2022/12/31 | (Q2)2022/09/30 | (Q1)2022/06/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | -7.88%225.96億 | 3.02%56.41億 | -9.26%58.41億 | -12.24%55.42億 | -11.58%55.71億 | 15.99%245.29億 | -1.58%54.76億 | 15.14%64.37億 | 28.42%63.15億 | 24.14%63.01億 |
| 主營業務成本 | -8.56%207.04億 | 2.35%51.87億 | -10.00%53.46億 | -13.43%50.55億 | -11.73%51.17億 | 16.14%226.43億 | -1.48%50.68億 | 15.47%59.4億 | 29.23%58.39億 | 23.56%57.97億 |
| 毛利 | 0.31%18.92億 | 11.41%4.54億 | -0.39%4.95億 | 2.39%4.87億 | -9.91%4.55億 | 14.25%18.86億 | -2.81%4.08億 | 11.28%4.97億 | 19.21%4.76億 | 31.17%5.05億 |
| 營業費用 | 3.85%14.51億 | 1.88%3.91億 | 3.15%3.55億 | 5.12%3.5億 | 5.56%3.56億 | 3.66%13.97億 | 10.36%3.83億 | 6.33%3.44億 | 3.65%3.33億 | -5.28%3.38億 |
| 營業利潤 | -9.81%4.4億 | 161.52%6,367.8萬 | -8.33%1.41億 | -3.93%1.38億 | -41.19%9,823.5萬 | 61.48%4.88億 | -66.24%2,434.9萬 | 24.22%1.53億 | 82.83%1.43億 | 490.71%1.67億 |
| 營業外利息收入與支出淨額 | 133.75%717.6萬 | 142.95%220.6萬 | 49.59%162.6萬 | 295.53%176.8萬 | 150.96%157.6萬 | 148.18%307萬 | 568.04%90.8萬 | 168.40%108.7萬 | -4.28%44.7萬 | 12.34%62.8萬 |
| 營業外利息收入 | 34.42%738.1萬 | 41.71%223.9萬 | 31.75%169.7萬 | 33.75%181.5萬 | 28.75%163萬 | 5.35%549.1萬 | 21.54%158萬 | -0.16%128.8萬 | 0.67%135.7萬 | -0.63%126.6萬 |
| 營業外利息支出 | -91.53%20.5萬 | -95.09%3.3萬 | -64.68%7.1萬 | -94.84%4.7萬 | -91.54%5.4萬 | -39.09%242.1萬 | -55.02%67.2萬 | -77.29%20.1萬 | 3.29%91萬 | -10.77%63.8萬 |
| 投資淨收益 | 10.63%1.82億 | 38.36%7,407.8萬 | 409.84%1,033.3萬 | -6.25%7,252.6萬 | -32.46%2,480萬 | 7.86%1.64億 | -18.47%5,354.1萬 | -120.82%-333.5萬 | 32.99%7,735.9萬 | 194.82%3,671.7萬 |
| 被指定為現金流套期的金融工具損益 | ||||||||||
| 終止確認可供出售金融資產損益 | ||||||||||
| 聯營企業及其他參股權益產生的收益 | ||||||||||
| 特殊收入（費用） | ||||||||||
| 其他營業外收入（費用） | 25.15%2,249.9萬 | 35.97%459.7萬 | 49.58%537.6萬 | 67.71%880.3萬 | -35.29%372.3萬 | -5.44%1,797.7萬 | 1,302.90%338.1萬 | -12.85%359.4萬 | -49.68%524.9萬 | 36.46%575.3萬 |
| 稅前利潤 | -3.24%6.52億 | 75.91%1.45億 | 2.07%1.58億 | -2.47%2.21億 | -38.93%1.28億 | -20.28%6.74億 | -83.82%8,217.9萬 | 7.43%1.55億 | 53.53%2.27億 | 361.78%2.1億 |
| 所得稅 | -15.44%1.6億 | -64.03%856.7萬 | 7.26%4,849.3萬 | -9.16%5,977.6萬 | -20.64%4,298萬 | -29.02%1.89億 | -84.62%2,381.4萬 | 6.20%4,521.1萬 | 46.44%6,580.3萬 | 126.77%5,415.8萬 |
| 除稅後利潤 | 1.52%4.92億 | 133.00%1.36億 | -0.07%1.09億 | 0.27%1.61億 | -45.28%8,535.2萬 | -16.26%4.85億 | -83.46%5,836.6萬 | 7.95%1.1億 | 56.64%1.61億 | 621.36%1.56億 |
| 持續經營利潤 | 1.52%4.92億 | 133.01%1.36億 | -0.07%1.09億 | 0.27%1.61億 | -45.28%8,535.3萬 | -16.26%4.85億 | -83.46%5,836.5萬 | 7.95%1.1億 | 56.64%1.61億 | 621.33%1.56億 |
| 歸屬于少數股東的淨利潤 | ||||||||||
| 歸屬於母公司的淨利潤 | 1.52%4.92億 | 133.00%1.36億 | -0.07%1.09億 | 0.27%1.61億 | -45.28%8,535.2萬 | -16.26%4.85億 | -83.46%5,836.6萬 | 7.95%1.1億 | 56.64%1.61億 | 621.36%1.56億 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 歸屬于普通股股東的淨利潤 | 1.52%4.92億 | 133.00%1.36億 | -0.07%1.09億 | 0.27%1.61億 | -45.28%8,535.2萬 | -16.26%4.85億 | -83.46%5,836.6萬 | 7.95%1.1億 | 56.64%1.61億 | 621.36%1.56億 |
| 總派息金額 | ||||||||||
| 基本每股收益 | 2.06%144.75 | 130.62%39.99 | -0.16%32.17 | 1.09%47.43 | -44.52%25.16 | -15.22%141.83 | -83.01%17.34 | 9.82%32.22 | 58.30%46.92 | 626.76%45.35 |
| 稀釋每股收益 | 2.06%144.75 | 132.38%39.9759 | -0.16%32.1684 | 1.09%47.43 | -44.52%25.16 | -15.22%141.83 | -83.15%17.2025 | 10.24%32.22 | 58.73%46.92 | 626.76%45.35 |
| 每股派息 | 5.56%38 | 5.56%38 | 0 | 0 | 0 | 50.00%36 | 50.00%36 | 0 | 0 | 0 |
| 貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
| 會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |